Breast cancer is the second leading cause of cancer death in women. Early detection results in 99% five-year survival rates.
Study projects rising breast cancer cases in India, with an estimated annual economic burden of $19.55 billion by 2030.
Two new studies have identified a possible way to block the progression of several forms of blood cancer using a drug already in clinical trials against breast cancer.
Since the exact cause is not known, it may not be easy to prevent breast cancer. However, reducing the risks of breast cancer ...
Cancer diagnoses are shifting from older to younger adults and from men to women, according to a report released Thursday by ...
Genetic testing is recommended for those with personal and family histories of several types of cancer — including pancreatic ...
Dr. Maxwell Lloyd shared the importance of improving patient access to innovative therapies like Orserdu at the 2024 San Antonio Breast Cancer Symposium.
On January 17, 2025, the Food and Drug Administration (FDA) approved datopotamab deruxtecan-dlnk a Trop-2-directed antibody ...
Dawn Klemow, MD, assistant clinical professor, University of Texas Southwestern Medical Center, previews some of the most recent advances in breast cancer treatment.
Dr. Maxwell Lloyd discusses the long-term management of patients with HR-positive, HER2-negative breast cancer who have received Orserdu treatment.
If you have been diagnosed with metastatic breast cancer, resources like support groups, counseling, financial assistance, and online communities can help.